Satish Mehta - Emcure Pharmaceuticals MD CEO

EMCURE Stock   1,421  33.45  2.41%   

CEO

Satish Mehta is MD CEO of Emcure Pharmaceuticals
Age 73
Address Plot No. P-1 and P-2, Pune, India, 411057
Phone91 20 3507 0033
Webhttps://www.emcure.com

Similar Executives

Found 1 records

CEO Age

Arvind KapurRico Auto Industries
74
Emcure Pharmaceuticals (EMCURE) is traded on National Stock Exchange of India in India and employs 10 people.

Emcure Pharmaceuticals Leadership Team

Elected by the shareholders, the Emcure Pharmaceuticals' board of directors comprises two types of representatives: Emcure Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Emcure. The board's role is to monitor Emcure Pharmaceuticals' management team and ensure that shareholders' interests are well served. Emcure Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Emcure Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Chetan Sharma, Company Officer
Vikas Thapar, Strategy Development
Rajesh Nair, Executive Resources
Satish Mehta, MD CEO
Samit Mehta, President Director
Naveen Soni, Director Relations
Mukund Gurjar, Chief Director
Namita Thapar, Executive Director
Tajuddin Shaikh, Chief Officer
Sunil Mehta, Executive Director

Emcure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Emcure Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Emcure Stock

Emcure Pharmaceuticals financial ratios help investors to determine whether Emcure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emcure with respect to the benefits of owning Emcure Pharmaceuticals security.